Your browser doesn't support javascript.
loading
Resolution of Clinical Signs of Sarcoptic Mange in American Black Bears (Ursus americanus), in Ivermectin-Treated and Nontreated Individuals.
Tiffin, Hannah S; Brown, Justin D; Ternent, Mark; Snavely, Brandon; Carrollo, Emily; Kibe, Ethan; Buderman, Frances E; Mullinax, Jennifer M; Machtinger, Erika T.
Afiliação
  • Tiffin HS; Department of Entomology, Pennsylvania State University, 4 Chemical Ecology Laboratory, University Park, Pennsylvania 16802, USA.
  • Brown JD; Department of Veterinary & Biomedical Sciences, Pennsylvania State University, 108D AVBS Building, Shortlidge Rd., University Park, Pennsylvania 16802, USA.
  • Ternent M; Pennsylvania Game Commission, 2001 Elmerton Ave., Harrisburg, Pennsylvania 17110, USA.
  • Snavely B; Pennsylvania Game Commission, 2001 Elmerton Ave., Harrisburg, Pennsylvania 17110, USA.
  • Carrollo E; Pennsylvania Game Commission, 2001 Elmerton Ave., Harrisburg, Pennsylvania 17110, USA.
  • Kibe E; Pennsylvania Game Commission, 2001 Elmerton Ave., Harrisburg, Pennsylvania 17110, USA.
  • Buderman FE; Department of Ecosystem Science & Management, Pennsylvania State University, 401 Forest Resources Building, University Park, Pennsylvania 16802, USA.
  • Mullinax JM; Department of Environmental Science & Technology, University of Maryland, 1433 Animal Science Building, 8127 Regents Dr., College Park, Maryland 20742, USA.
  • Machtinger ET; Department of Entomology, Pennsylvania State University, 4 Chemical Ecology Laboratory, University Park, Pennsylvania 16802, USA.
J Wildl Dis ; 60(2): 434-447, 2024 04 01.
Article em En | MEDLINE | ID: mdl-38305090
ABSTRACT
The parasitic mite Sarcoptes scabiei causes mange in nearly 150 species of mammals by burrowing under the skin, triggering hypersensitivity responses that can alter animals' behavior and result in extreme weight loss, secondary infections, and even death. Since the 1990s, sarcoptic mange has increased in incidence and geographic distribution in Pennsylvania black bear (Ursus americanus) populations, including expansion into other states. Recovery from mange in free-ranging wildlife has rarely been evaluated. Following the Pennsylvania Game Commission's standard operating procedures at the time of the study, treatment consisted of one subcutaneous injection of ivermectin. To evaluate black bear survival and recovery from mange, from 2018 to 2020 we fitted 61 bears, including 43 with mange, with GPS collars to track their movements and recovery. Bears were collared in triplicates according to sex and habitat, consisting of one bear without mange (healthy control), one scabietic bear treated with ivermectin when collared, and one untreated scabietic bear. Bears were reevaluated for signs of mange during annual den visits, if recaptured during the study period, and after mortality events. Disease status and recovery from mange was determined based on outward gross appearance and presence of S. scabiei mites from skin scrapes. Of the 36 scabietic bears with known recovery status, 81% fully recovered regardless of treatment, with 88% recovered with treatment and 74% recovered without treatment. All bears with no, low, or moderate mite burdens (<16 mites on skin scrapes) fully recovered from mange (n=20), and nearly half of bears with severe mite burden (≥16 mites) fully recovered (n=5, 42%). However, nonrecovered status did not indicate mortality, and mange-related mortality was infrequent. Most bears were able to recover from mange irrespective of treatment, potentially indicating a need for reevaluation of the mange wildlife management paradigm.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escabiose / Ursidae Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escabiose / Ursidae Idioma: En Ano de publicação: 2024 Tipo de documento: Article